Poliomyelitis - 42 Studies Found Completed : 3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants : Poliomyelitis : 2015-01-15 : Biological: Primary series of immunisation comprised by 3 vaccinations IPV-A Completed : Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine : Poliomyelitis : 2016-05-25 : Biological: poliovirus vaccine Different vaccination schedules with bOPV, tOPV and cIPV would be provide Completed : Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults : Poliomyelitis : 2012-10-15 : Drug: IPV Other Names: Completed : Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV : Poliomyelitis Polio : 2006-07-03 : Biological: Poliomyelitis Vaccine inactivated Recruiting : Safety and Immunogenicity of IPOVAC in Young Children : Poliomyelitis : 2016-05-05 : Biological: IMOVAC-POLIO IMOVA Withdrawn : A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome : Postpoliomyelitis Syndrome : 2012-03-07 : Drug: L-carnitine and piracetam Terminated : Modafinil to Treat Fatigue in Post-Polio Syndrome : Postpoliomyelitis Syndrome : 2003-08-20 : Drug: Modafinil Active, not recruiting : L-Citrulline in Patients With Post-Polio Syndrome : Post-Polio Syndrome : 2016-06-06 : Drug: 15g L-citrulline daily p.o. Drug: Pl Recruiting : Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome : Post-polio Syndrome : 2014-06-25 : Biological: Flebogamma 5% DIF Completed : Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS) : Post Polio Syndrome, PPS : 2005-09-09 : Drug: Xepol <<< Previous | Next >>>